Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Results of Annual General Meeting

21st May 2013 07:00

RNS Number : 1839F
Cathay International Holdings Ld
21 May 2013
 

Cathay International Holdings Limited

("Cathay" or the "Company")

 

Results of Annual General Meeting

 

Hong Kong, 21 May 2013 - Cathay International Holdings Ltd. (LSE: CTI.L), a main market listed investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China ("PRC"), today announces that at the Annual General Meeting held earlier today all resolutions were duly passed. For further details on polling voting results, please visit the Company's website at www.cathay-intl.com.hk

 

Copies of all special resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do.

 

- END -

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

Tel: +852 2828 9289

 

M:Communications

Mary-Jane Elliott / Amber Bielecka / Claire Dickinson

 

 

Tel: +44 (0)20 7920 2330

 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China ("PRC"). Taking advantage of the strong and growing domestic demand for high quality healthcare products in China, Cathay aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen Group, China's leading specialty pharmaceutical company focused on rheumatology, Haotian Group, a company engaged in the manufacture, marketing and sale of key active ingredients for healthcare products, including dietary supplement inositol and Botai, a company engaged in the development of pharmaceutical products and bringing these to the growing Chinese market.

The Group employs more than 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a private equity investment arm focused on minority investment opportunities and a hotel investment.

For more information please visit the Company's website: www.cathay-intl.com.hk

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGABMATMBITMAJ

Related Shares:

CTI.L
FTSE 100 Latest
Value8,275.66
Change0.00